These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21372494)

  • 1. Effect of histone deacetylase inhibitor in combination with 5-fluorouracil on pancreas cancer and cholangiocarcinoma cell lines.
    Iwahashi S; Ishibashi H; Utsunomiya T; Morine Y; Ochir TL; Hanaoka J; Mori H; Ikemoto T; Imura S; Shimada M
    J Med Invest; 2011 Feb; 58(1-2):106-9. PubMed ID: 21372494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylases and their inhibitors as potential therapeutic drugs for cholangiocarcinoma - cell line findings.
    Sriraksa R; Limpaiboon T
    Asian Pac J Cancer Prev; 2013; 14(4):2503-8. PubMed ID: 23725164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of valproic acid in combination with S-1 on advanced pancreatobiliary tract cancers: clinical study phases I/II.
    Iwahashi S; Utsunomiya T; Imura S; Morine Y; Ikemoto T; Arakawa Y; Saito Y; Ishikawa D; Shimada M
    Anticancer Res; 2014 Sep; 34(9):5187-91. PubMed ID: 25202113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitor enhances the anti-tumor effect of gemcitabine: a special reference to gene-expression microarray analysis.
    Iwahashi S; Shimada M; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Mori H; Hanaoka J; Saito Y
    Oncol Rep; 2011 Nov; 26(5):1057-62. PubMed ID: 21805043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CG200745, an HDAC inhibitor, induces anti-tumour effects in cholangiocarcinoma cell lines via miRNAs targeting the Hippo pathway.
    Jung DE; Park SB; Kim K; Kim C; Song SY
    Sci Rep; 2017 Sep; 7(1):10921. PubMed ID: 28883618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitor augments anti-tumor effect of gemcitabine and pegylated interferon-α on pancreatic cancer cells.
    Iwahashi S; Shimada M; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Mori H; Hanaoka J; Sugimoto K; Saito Y
    Int J Clin Oncol; 2011 Dec; 16(6):671-8. PubMed ID: 21556798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raddeanin A promotes apoptosis and ameliorates 5-fluorouracil resistance in cholangiocarcinoma cells.
    Guo SS; Wang Y; Fan QX
    World J Gastroenterol; 2019 Jul; 25(26):3380-3391. PubMed ID: 31341363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch1 is overexpressed in human intrahepatic cholangiocarcinoma and is associated with its proliferation, invasiveness and sensitivity to 5-fluorouracil in vitro.
    Wu WR; Zhang R; Shi XD; Zhu MS; Xu LB; Zeng H; Liu C
    Oncol Rep; 2014 Jun; 31(6):2515-24. PubMed ID: 24700253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXM1 inhibitor, Siomycin A, synergizes and restores 5-FU cytotoxicity in human cholangiocarcinoma cell lines via targeting thymidylate synthase.
    Klinhom-On N; Seubwai W; Sawanyawisuth K; Obchoei S; Mahalapbutr P; Wongkham S
    Life Sci; 2021 Dec; 286():120072. PubMed ID: 34688691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAIL in Combination with Subtoxic 5-FU Effectively Inhibit Cell Proliferation and Induce Apoptosis in Cholangiocarcinoma Cells.
    Sriraksa R; Limpaiboon T
    Asian Pac J Cancer Prev; 2015; 16(16):6991-6. PubMed ID: 26514480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer effects of the combined Thai noni juice ethanolic extracts and 5-fluorouracil against cholangiocarcinoma cells in vitro and in vivo.
    Prompipak J; Senawong T; Sripa B; Ketterman AJ; Utaiwat S; Woranam K; Jeeunngoi J; Senawong G
    Sci Rep; 2021 Jul; 11(1):14866. PubMed ID: 34290264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic Effect of Forbesione From Garcinia hanburyi in Combination with 5-Fluorouracil on Cholangiocarcinoma.
    Boueroy P; Hahnvajanawong C; Boonmars T; Saensa-ard S; Wattanawongdon W; Kongsanthia C; Salao K; Wongwajana S; Anantachoke N; Reutrakul V
    Asian Pac J Cancer Prev; 2017 Dec; 18(12):3343-3351. PubMed ID: 29286229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors.
    Tarasenko N; Chekroun-Setti H; Nudelman A; Rephaeli A
    J Cell Biochem; 2018 Apr; 119(4):3417-3428. PubMed ID: 29135083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid enhances the anti-tumor effect of pegylated interferon-α towards pancreatic cancer cell lines.
    Sugimoto K; Shimada M; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Iwahashi S
    Anticancer Res; 2014 Jul; 34(7):3403-9. PubMed ID: 24982347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma.
    Guion-Dusserre JF; Lorgis V; Vincent J; Bengrine L; Ghiringhelli F
    World J Gastroenterol; 2015 Feb; 21(7):2096-101. PubMed ID: 25717243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDAC inhibitors, trichostatin A and valproic acid, increase E‑cadherin and vimentin expression but inhibit migration and invasion of cholangiocarcinoma cells.
    Wang JH; Lee EJ; Ji M; Park SM
    Oncol Rep; 2018 Jul; 40(1):346-354. PubMed ID: 29767267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells.
    Gilardini Montani MS; Granato M; Santoni C; Del Porto P; Merendino N; D'Orazi G; Faggioni A; Cirone M
    Cell Oncol (Dordr); 2017 Apr; 40(2):167-180. PubMed ID: 28160167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of hepatic arterial infusion chemotherapy using 5-fluorouracil and systemic pegylated interferon α-2b for advanced intrahepatic cholangiocarcinoma.
    Kasai K; Kooka Y; Suzuki Y; Suzuki A; Oikawa T; Ushio A; Kasai Y; Sawara K; Miyamoto Y; Oikawa K; Takikawa Y
    Ann Surg Oncol; 2014 Oct; 21(11):3638-45. PubMed ID: 24817369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic anticancer effects of cisplatin and histone deacetylase inhibitors (SAHA and TSA) on cholangiocarcinoma cell lines.
    Asgar MA; Senawong G; Sripa B; Senawong T
    Int J Oncol; 2016 Jan; 48(1):409-20. PubMed ID: 26575528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Histone Deacetylase Inhibitor Valproic Acid Sensitizes Gemcitabine-Induced Cytotoxicity in Gemcitabine-Resistant Pancreatic Cancer Cells Possibly Through Inhibition of the DNA Repair Protein Gamma-H2AX.
    Wang Y; Kuramitsu Y; Kitagawa T; Tokuda K; Baron B; Akada J; Nakamura K
    Target Oncol; 2015 Dec; 10(4):575-81. PubMed ID: 25940934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.